News for Mereo BioPharma Group PLC (MPH.L)

Significant Transaction in Mereo BioPharma On December 31, 2024, ADAGE CAPITAL PARTNERS GP, L.L.C. (Trades, Portfolio) executed a notable transaction by acquiri

Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.

Mereo BioPharma Provides Update on Lead Clinical Programs

LONDON, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc ( MREO) (”œMereo” or the ”œCompany”), a clinical-stage biopharmaceutical company foc

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

U.S. stocks traded mostly higher midway through trading, with the S&P 500 gaining around 0.4% on Monday. The Dow traded down 0.08% to 43,794.43 while the NASDA...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

Mereo BioPharma's chief scientific officer sells shares worth over $69,000

Mereo BioPharma's general counsel sells over $133k in company stock

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

Roth MKM analysts updated their top ideas within their ADR universe.

U.S. stock futures were slightly higher this morning, with the S&P 500 futures gaining around 0.1% on Monday. Shares of Liquidia Corporation LQDA fell sharply ...

Shares of Xperi Inc. XPER rose sharply in today's pre-market trading after the company announced that it entered into an agreement with Amazon.com services for ...

C4X Discovery Holdings Limited C4XD announces progress on immuno-inflammation programmes and appointment of new Board members 22 July 2024 - C4X...

Loading... Loading... Shares of Streamline Health Solutions, Inc. STRM fell sharply during Wednesday's session after the company reported worse-than-expected f...

Loading... Loading... Shares of Oracle Corporation ORCL rose sharply in today's pre-market trading after the company reported fourth-quarter financial results....

/PRNewswire/ -- The bispecific antibodies for cancer market size is forecasted to increase by USD 400.72 million from 2022 to 2027, at a CAGR of 8.82%,...

According to Market.us, the global alpha-1 antitrypsin deficiency augmentation therapy market growth is driven by the increase in the prevalence of Genetic...

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To be held on November 17, 2022 Dear Shareholder: We cordially invite you to attend the Annual... | October 5, 2022